Figure 1From: Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations Cancer onset age in the BRCA1/2 mutation carriers (A) and BRCA1/2 non carriers (B), according to their MDM2 SNP-309 subtypes. C and D prevalence of the SNP MDM309 genotypes in women above and bellow 51 years old – C total carrier population and D only BRCA1 mutation carriers.Back to article page